Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

Stephen A. Boorjian, Colin P. Dinney, Badrinath R. Konety et al.|The Lancet Oncology|2020

Cited by 459